CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.
- 14 December 1974
- journal article
- Published by Elsevier in The Lancet
- Vol. 304 (7894) , 1405-1409
- https://doi.org/10.1016/s0140-6736(74)90070-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. ParvumInternational Journal of Cancer, 1974
- Serial Studies of Immunocompetence of Patients Undergoing Chemotherapy for Acute LeukemiaJournal of Clinical Investigation, 1974
- THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamideArchives of internal medicine (1960), 1974
- Active Immunotherapy Used Alone for Maintenance of Patients with Acute Myeloid LeukaemiaBMJ, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous LeukaemiaBMJ, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958